Tumor-derived antibodies for multifaceted immunotherapeutic targeting of human ovarian cancer
29:23
Emerging Immunotherapeutics for Ovarian Cancer Symposium - Panel Discussion
56:17
Versatility of Modular Antibodies: Rapid Format Switch to Fast Screening of Libraries & Bispecifics
43:28
Strategies for Mitigating the Unpredictability of Fc-Mediated Functions in Antibody Development
1:09:57
Avoid Thy Neighbor: Antibody Discovery Lessons from Successful LILRB1/2 Targeted Myeloid Suppression
18:07
Interview with Virginia Metrangolo (University of Copenhagen)
1:09:35
Antibodies to watch in 2024
52:50
Exploring TCR-Epitope Prediction Tools: Insights And Pitfalls
1:34:06